Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice

Joon Youb Lee, Dong Hyeon Kim, Yeonseok Chung, Seung-Uon Shin, Chang Yuil Kang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The relative importance of CTL and antibodies in rejecting Her-2/neu-expressing tumors was evaluated in preventive and therapeutic models by DNA vaccination. Four human Her-2/neu-expressing plasmids (pNeuTM, pNeuECD, pNeuTM-gDs, and pNeuECD-gDs) were generated encoding either the transmembrane and extracellular domains or the extracellular domain. Interestingly, these plasmids demonstrated substantial difference in inducing Her-2/neu-specific serum IgG according to their signal sequence when injected in BALB/c mice. pNeuTM and pNeuECD induced high serum IgG titers. pNeuTM-gDs and pNeuECD-gDs induced low or very low serum IgG titers, respectively. As a result, mice vaccinated with not only pNeuECD but also pNeuECD-gDs exhibited complete eradication of a small number of tumor cells. Nevertheless, when the number of tumor cells was increased in a therapeutic model, only pNeuECD exhibited statistically significant antitumor immunity. These studies demonstrate that strong CTL may be sufficient in tumor prevention, but the collaboration of CTL and antibody may be required in tumor therapy.

Original languageEnglish
Pages (from-to)521-531
Number of pages11
JournalVaccine
Volume21
Issue number5-6
DOIs
StatePublished - Jan 17 2003

Fingerprint

DNA Vaccines
recombinant vaccines
Immunity
Immunoglobulin G
immunity
therapeutics
neoplasms
plasmids
mice
Neoplasms
antibodies
signal peptide
Plasmids
Cell Count
Serum
vaccination
Antibodies
Protein Sorting Signals
DNA
Vaccination

Keywords

  • DNA vaccine
  • Her-2/neu
  • Tumor immunotherapy

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice. / Lee, Joon Youb; Kim, Dong Hyeon; Chung, Yeonseok; Shin, Seung-Uon; Kang, Chang Yuil.

In: Vaccine, Vol. 21, No. 5-6, 17.01.2003, p. 521-531.

Research output: Contribution to journalArticle

Lee, Joon Youb ; Kim, Dong Hyeon ; Chung, Yeonseok ; Shin, Seung-Uon ; Kang, Chang Yuil. / Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice. In: Vaccine. 2003 ; Vol. 21, No. 5-6. pp. 521-531.
@article{3b5ff21fcc184333bfbd3a43cc60de82,
title = "Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice",
abstract = "The relative importance of CTL and antibodies in rejecting Her-2/neu-expressing tumors was evaluated in preventive and therapeutic models by DNA vaccination. Four human Her-2/neu-expressing plasmids (pNeuTM, pNeuECD, pNeuTM-gDs, and pNeuECD-gDs) were generated encoding either the transmembrane and extracellular domains or the extracellular domain. Interestingly, these plasmids demonstrated substantial difference in inducing Her-2/neu-specific serum IgG according to their signal sequence when injected in BALB/c mice. pNeuTM and pNeuECD induced high serum IgG titers. pNeuTM-gDs and pNeuECD-gDs induced low or very low serum IgG titers, respectively. As a result, mice vaccinated with not only pNeuECD but also pNeuECD-gDs exhibited complete eradication of a small number of tumor cells. Nevertheless, when the number of tumor cells was increased in a therapeutic model, only pNeuECD exhibited statistically significant antitumor immunity. These studies demonstrate that strong CTL may be sufficient in tumor prevention, but the collaboration of CTL and antibody may be required in tumor therapy.",
keywords = "DNA vaccine, Her-2/neu, Tumor immunotherapy",
author = "Lee, {Joon Youb} and Kim, {Dong Hyeon} and Yeonseok Chung and Seung-Uon Shin and Kang, {Chang Yuil}",
year = "2003",
month = "1",
day = "17",
doi = "10.1016/S0264-410X(02)00470-X",
language = "English",
volume = "21",
pages = "521--531",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "5-6",

}

TY - JOUR

T1 - Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice

AU - Lee, Joon Youb

AU - Kim, Dong Hyeon

AU - Chung, Yeonseok

AU - Shin, Seung-Uon

AU - Kang, Chang Yuil

PY - 2003/1/17

Y1 - 2003/1/17

N2 - The relative importance of CTL and antibodies in rejecting Her-2/neu-expressing tumors was evaluated in preventive and therapeutic models by DNA vaccination. Four human Her-2/neu-expressing plasmids (pNeuTM, pNeuECD, pNeuTM-gDs, and pNeuECD-gDs) were generated encoding either the transmembrane and extracellular domains or the extracellular domain. Interestingly, these plasmids demonstrated substantial difference in inducing Her-2/neu-specific serum IgG according to their signal sequence when injected in BALB/c mice. pNeuTM and pNeuECD induced high serum IgG titers. pNeuTM-gDs and pNeuECD-gDs induced low or very low serum IgG titers, respectively. As a result, mice vaccinated with not only pNeuECD but also pNeuECD-gDs exhibited complete eradication of a small number of tumor cells. Nevertheless, when the number of tumor cells was increased in a therapeutic model, only pNeuECD exhibited statistically significant antitumor immunity. These studies demonstrate that strong CTL may be sufficient in tumor prevention, but the collaboration of CTL and antibody may be required in tumor therapy.

AB - The relative importance of CTL and antibodies in rejecting Her-2/neu-expressing tumors was evaluated in preventive and therapeutic models by DNA vaccination. Four human Her-2/neu-expressing plasmids (pNeuTM, pNeuECD, pNeuTM-gDs, and pNeuECD-gDs) were generated encoding either the transmembrane and extracellular domains or the extracellular domain. Interestingly, these plasmids demonstrated substantial difference in inducing Her-2/neu-specific serum IgG according to their signal sequence when injected in BALB/c mice. pNeuTM and pNeuECD induced high serum IgG titers. pNeuTM-gDs and pNeuECD-gDs induced low or very low serum IgG titers, respectively. As a result, mice vaccinated with not only pNeuECD but also pNeuECD-gDs exhibited complete eradication of a small number of tumor cells. Nevertheless, when the number of tumor cells was increased in a therapeutic model, only pNeuECD exhibited statistically significant antitumor immunity. These studies demonstrate that strong CTL may be sufficient in tumor prevention, but the collaboration of CTL and antibody may be required in tumor therapy.

KW - DNA vaccine

KW - Her-2/neu

KW - Tumor immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=0037449518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037449518&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(02)00470-X

DO - 10.1016/S0264-410X(02)00470-X

M3 - Article

VL - 21

SP - 521

EP - 531

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 5-6

ER -